111 related articles for article (PubMed ID: 15840775)
1. Impaired cytotoxicity in Papillon-Lefèvre syndrome.
Lundgren T; Parhar RS; Renvert S; Tatakis DN
J Dent Res; 2005 May; 84(5):414-7. PubMed ID: 15840775
[TBL] [Abstract][Full Text] [Related]
2. Immunological study of patients with the Papillon--Lefevre syndrome.
Levo Y; Wollner S; Hacham-Zadeh S
Clin Exp Immunol; 1980 May; 40(2):407-10. PubMed ID: 6449328
[TBL] [Abstract][Full Text] [Related]
3. Characterization of neutrophil function in Papillon-Lefèvre syndrome.
Roberts H; White P; Dias I; McKaig S; Veeramachaneni R; Thakker N; Grant M; Chapple I
J Leukoc Biol; 2016 Aug; 100(2):433-44. PubMed ID: 26957212
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
6. Papillon-Lefèvre syndrome. Characterization of peripheral blood and gingival lymphocytes with monoclonal antibodies.
Celenligil H; Kansu E; Ruacan S; Eratalay K
J Clin Periodontol; 1992 Jul; 19(6):392-7. PubMed ID: 1353082
[TBL] [Abstract][Full Text] [Related]
7. Papillon-Lefèvre syndrome. Analysis of peripheral blood lymphocyte subsets.
Firatli E; Gürel N; Efeoğlu A
J Clin Periodontol; 1996 Sep; 23(9):823-5. PubMed ID: 8891932
[TBL] [Abstract][Full Text] [Related]
8. Papillon-Lefèvre syndrome. Analysis of neutrophil chemotaxis.
Firatli E; Tüzün B; Efeoğlu A
J Periodontol; 1996 Jun; 67(6):617-20. PubMed ID: 8794974
[TBL] [Abstract][Full Text] [Related]
9. A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity.
Meade JL; de Wynter EA; Brett P; Sharif SM; Woods CG; Markham AF; Cook GP
Blood; 2006 May; 107(9):3665-8. PubMed ID: 16410452
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.
Villanueva J; Lee S; Giannini EH; Graham TB; Passo MH; Filipovich A; Grom AA
Arthritis Res Ther; 2005; 7(1):R30-7. PubMed ID: 15642140
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological findings in 2 siblings with Papillon-Lefèvre syndrome.
Firatli E; Gürel N; Efeoglu A; Badur S
J Periodontol; 1996 Nov; 67(11):1210-5. PubMed ID: 8959572
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
[TBL] [Abstract][Full Text] [Related]
13. Reference values for peripheral blood lymphocytes from Aotus lemurinus ssp. griseimembra (owl monkey).
Caldwell CW; Mrema JE; Taylor HM; Green TJ
J Med Primatol; 1987; 16(4):261-71. PubMed ID: 2957504
[TBL] [Abstract][Full Text] [Related]
14. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
Brown TE; Bankhurst AD; Strickland RG
J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
[TBL] [Abstract][Full Text] [Related]
17. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
Jang YY; Cho D; Kim SK; Shin DJ; Park MH; Lee JJ; Shin MG; Shin JH; Suh SP; Ryang DW
Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic reactivity of human natural killer (NK) cells during normal pregnancy: a longitudinal study.
Gregory CD; Shah LP; Lee H; Scott IV; Golding PR
J Clin Lab Immunol; 1985 Dec; 18(4):175-81. PubMed ID: 3879503
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
Karlsson FA; Tötterman TH
Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
[TBL] [Abstract][Full Text] [Related]
20. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
Dons'koi BV; Chernyshov VP; Osypchuk DV
J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
